Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
417 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04054908 | Gut Microbiome in Colorectal Cancer(GO) | completed | — | 50 | University of California, San FranciscoOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT04636905 | Evaluation of Survivorship Wellness Group Program for Patients Treated at University of California, San Francisco (UCSF) | completed | — | 53 | University of California, San FranciscoOTHER | 1 | Jun 14, 2024 |
| clinicaltrials |
| NCT05324098 | Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy | completed | N/A | 47 | University of California, San FranciscoOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT05127850 | MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer | completed | N/A | 51 | University of California, San FranciscoOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05359042 | Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers | withdrawn | N/A | 0 | University of California, San FranciscoOTHER | 0 | May 8, 2024 | clinicaltrials |
| NCT04407442 | Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab | terminated | Phase 2 | 5 | University of California, San FranciscoOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT00804128 | Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS) | completed | — | 76 | University of California, San FranciscoOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT05227027 | Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation | completed | N/A | 500 | University of California, San FranciscoOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT02060890 | Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma(TGEN) | completed | — | 20 | University of California, San FranciscoOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT03609840 | Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients | completed | — | 25 | University of California, San FranciscoOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT04149249 | CONNECT: Smoking Cessation and Lung Cancer Screening | completed | N/A | 99 | University of California, San FranciscoOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT04190056 | Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer | terminated | Phase 2 | 1 | University of California, San FranciscoOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT04409314 | Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy | completed | — | 23 | University of California, San FranciscoOTHER | 1 | Aug 21, 2023 | clinicaltrials |
| NCT04697524 | Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer | completed | N/A | 30 | University of California, San FranciscoOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT04589286 | Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing Transplantation | completed | N/A | 60 | University of California, San FranciscoOTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT02022644 | Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma | completed | Phase 1 | 18 | University of California, San FranciscoOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT03397160 | Pioneering Advances in Care and Education (PACE)(PACE) | completed | N/A | 119 | University of California, San FranciscoOTHER | 1 | Jun 12, 2023 | clinicaltrials |
| NCT00227617 | Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors | terminated | Phase 2 / Phase 3 | 36 | University of California, San FranciscoOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT04630015 | Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth | completed | — | 134 | University of California, San FranciscoOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT04605211 | A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors | completed | N/A | 47 | University of California, San FranciscoOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05362331 | Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy | withdrawn | N/A | 0 | University of California, San FranciscoOTHER | 0 | Feb 9, 2023 | clinicaltrials |
| NCT04191967 | Thermocoagulation for Treatment of Precancerous Cervical Lesions | completed | N/A | 379 | University of California, San FranciscoOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT03867916 | Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients | completed | N/A | 106 | University of California, San FranciscoOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT04044430 | Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer | terminated | Phase 1 | 2 | University of California, San FranciscoOTHER | 1 | Jan 9, 2023 | clinicaltrials |
| NCT04597151 | Diet Education Program for Stage I-IV Colorectal Cancer Survivors | completed | N/A | 13 | University of California, San FranciscoOTHER | 1 | Jan 9, 2023 | clinicaltrials |
| NCT02023905 | Everolimus With and Without Temozolomide in Adult Low Grade Glioma | terminated | Phase 2 | 27 | University of California, San FranciscoOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT03087448 | Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 1 | 9 | University of California, San FranciscoOTHER | 1 | Dec 27, 2022 | clinicaltrials |
| NCT03136055 | Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas | completed | Phase 2 | 36 | University of California, San FranciscoOTHER | 1 | Dec 27, 2022 | clinicaltrials |
| NCT04326660 | SCOPE-Chinese Women Study(SCOPE) | completed | N/A | 40 | University of California, San FranciscoOTHER | 2 | Dec 22, 2022 | clinicaltrials |
| NCT02190097 | Paleo Versus Healthy ADA Diets for Treatment of Polycystic Ovarian Syndrome (PCOS) | completed | N/A | 15 | University of California, San FranciscoOTHER | 1 | Dec 1, 2022 | clinicaltrials |
| NCT02274987 | Molecular Profiling for Individualized Treatment Plan for DIPG | completed | N/A | 38 | University of California, San FranciscoOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT04005144 | Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer | terminated | Phase 1 | 3 | University of California, San FranciscoOTHER | 1 | Oct 17, 2022 | clinicaltrials |
| NCT03396952 | Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma | completed | Phase 2 | 27 | University of California, San FranciscoOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT03857087 | 68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer | completed | — | 7 | University of California, San FranciscoOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05505539 | Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia(OL_5FU) | withdrawn | Phase 1 | 0 | University of California, San FranciscoOTHER | 1 | Sep 22, 2022 | clinicaltrials |
| NCT04876378 | Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand | terminated | — | 8 | University of California, San FranciscoOTHER | 1 | Sep 9, 2022 | clinicaltrials |
| NCT02613273 | CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer(CHAMP) | completed | N/A | 28 | University of California, San FranciscoOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03553732 | An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital | terminated | — | 48 | University of California, San FranciscoOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT02602327 | Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases | completed | Phase 1 | 21 | University of California, San FranciscoOTHER | 1 | Aug 1, 2022 | clinicaltrials |
| NCT05021172 | Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults | completed | N/A | 75 | University of California, San FranciscoOTHER | 1 | Jul 11, 2022 | clinicaltrials |
| NCT01452854 | Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide(OVA-LGG) | terminated | — | 2 | University of California, San FranciscoOTHER | 1 | Jul 8, 2022 | clinicaltrials |
| NCT03546322 | Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers | completed | — | 802 | University of California, San FranciscoOTHER | 1 | Jul 1, 2022 | clinicaltrials |
| NCT04870320 | Study of Attention and Memory Treatments for Cancer Survivors | completed | N/A | 49 | University of California, San FranciscoOTHER | 1 | Apr 8, 2022 | clinicaltrials |
| NCT02390011 | Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies | completed | — | 7 | University of California, San FranciscoOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT02384239 | A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer | completed | Phase 2 | 70 | University of California, San FranciscoOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT02866695 | Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients | completed | Phase 4 | 20 | University of California, San FranciscoOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT03322293 | Daylight Photodynamic Therapy for Actinic Keratosis | completed | Phase 1 | 24 | University of California, San FranciscoOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT04061590 | Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer | withdrawn | Phase 2 | 0 | University of California, San FranciscoOTHER | 1 | Mar 4, 2022 | clinicaltrials |
| NCT03943082 | Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials | terminated | N/A | 252 | University of California, San FranciscoOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT03905720 | Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient Services(PRACXIS) | completed | N/A | 448 | University of California, San FranciscoOTHER | 1 | Oct 22, 2021 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials